Robert G. Maki
Memorial Sloan-Kettering Cancer Center
New York
NY 10065-6007
USA
Name/email consistency: high
- Small is beautiful: insulin-like growth factors and their role in growth, development, and cancer. Maki, R.G. J. Clin. Oncol. (2010)
- Phase II study of sorafenib in patients with metastatic or recurrent sarcomas. Maki, R.G., D'Adamo, D.R., Keohan, M.L., Saulle, M., Schuetze, S.M., Undevia, S.D., Livingston, M.B., Cooney, M.M., Hensley, M.L., Mita, M.M., Takimoto, C.H., Kraft, A.S., Elias, A.D., Brockstein, B., Blachère, N.E., Edgar, M.A., Schwartz, L.H., Qin, L.X., Antonescu, C.R., Schwartz, G.K. J. Clin. Oncol. (2009)
- Pediatric sarcomas occurring in adults. Maki, R.G. J. Surg. Oncol (2008)
- Gemcitabine and docetaxel in metastatic sarcoma: past, present, and future. Maki, R.G. Oncologist (2007)
- A phase I pilot study of autologous heat shock protein vaccine HSPPC-96 in patients with resected pancreatic adenocarcinoma. Maki, R.G., Livingston, P.O., Lewis, J.J., Janetzki, S., Klimstra, D., Desantis, D., Srivastava, P.K., Brennan, M.F. Dig. Dis. Sci. (2007)
- Randomized phase II study of gemcitabine and docetaxel compared with gemcitabine alone in patients with metastatic soft tissue sarcomas: results of sarcoma alliance for research through collaboration study 002 [corrected]. Maki, R.G., Wathen, J.K., Patel, S.R., Priebat, D.A., Okuno, S.H., Samuels, B., Fanucchi, M., Harmon, D.C., Schuetze, S.M., Reinke, D., Thall, P.F., Benjamin, R.S., Baker, L.H., Hensley, M.L. J. Clin. Oncol. (2007)
- Future directions for immunotherapeutic intervention against sarcomas. Maki, R.G. Curr. Opin. Oncol (2006)
- A multicenter Phase II study of bortezomib in recurrent or metastatic sarcomas. Maki, R.G., Kraft, A.S., Scheu, K., Yamada, J., Wadler, S., Antonescu, C.R., Wright, J.J., Schwartz, G.K. Cancer (2005)
- Gastrointestinal Stromal Tumors Respond to Tyrosine Kinase-targeted Therapy. Maki, R.G. Curr. Treat. Options. Gastroenterol (2004)
- Role of chemotherapy in patients with soft tissue sarcomas. Maki, R.G. Expert. Rev. Anticancer. Ther (2004)
- Immunity against soft-tissue sarcomas. Maki, R.G. Curr. Oncol. Rep (2003)
- Multidisciplinary management of soft-tissue sarcomas. Maki, R.G. Cancer Invest. (2002)
- Differential sensitivity to imatinib of 2 patients with metastatic sarcoma arising from dermatofibrosarcoma protuberans. Maki, R.G., Awan, R.A., Dixon, R.H., Jhanwar, S., Antonescu, C.R. Int. J. Cancer (2002)
- Soft tissue sarcoma as a model disease to examine cancer immunotherapy. Maki, R.G. Curr. Opin. Oncol (2001)
- Sarcoma. Maki, R. Oncologist (2001)